|
TMEM182 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.167700E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.103900E-03 |
| Normal-vs-Stage2 |
1.148430E-02 |
| Normal-vs-Stage3 |
1.344420E-03 |
| Normal-vs-Stage4 |
1.400440E-04 |
| Stage1-vs-Stage2 |
9.027200E-01 |
| Stage1-vs-Stage3 |
6.376400E-01 |
| Stage1-vs-Stage4 |
1.031020E-01 |
| Stage2-vs-Stage3 |
8.285400E-01 |
| Stage2-vs-Stage4 |
2.137000E-01 |
| Stage3-vs-Stage4 |
2.126000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.006500E-04 |
| Normal-vs-AfricanAmerican |
3.041200E-01 |
| Normal-vs-Asian |
1.583360E-03 |
| Caucasian-vs-AfricanAmerican |
1.359580E-01 |
| Caucasian-vs-Asian |
6.049400E-01 |
| AfricanAmerican-vs-Asian |
1.178430E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.2592000000008E-05 |
| Normal-vs-Female |
3.036800E-03 |
| Male-vs-Female |
5.530000E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.596200E-03 |
| Normal-vs-Age(41-60Yrs) |
3.197300E-04 |
| Normal-vs-Age(61-80Yrs) |
5.280000E-03 |
| Normal-vs-Age(81-100Yrs) |
1.371600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.603600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.222800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.846600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.722400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.831000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.492800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.128760E-01 |
| Classical-VS-Follicular |
2.510200E-01 |
| Classical-VS-Other |
1.269590E-01 |
| Classical-VS-Normal |
7.446200E-04 |
| Tall-VS-Follicular |
3.671500E-02 |
| Tall-VS-Other |
2.818400E-01 |
| Tall-VS-Normal |
4.366500E-04 |
| Follicular-VS-Other |
1.296240E-01 |
| Follicular-VS-Normal |
8.352200E-02 |
| Other-VS-Normal |
5.497000E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.118100E-03 |
| Normal-vs-N1 |
4.9774000000502E-06 |
| N0-vs-N1 |
2.974100E-02 |
|
|
